Ana Belen Arauz, MD

Associate Professor of Medicine
Hospital Santo Tomas

Disclosure: Mayne Pharma (Individual(s) Involved: Self): Scientific Research Study Investigator

Presentation(s):

• 144 - MSG-15: Pharmacokinetic (PK), Adverse Events (AEs), and Tolerability Data from an Open Label Randomized Clinical Trial (RCT) Comparing Oral Suba-itraconazole (SUBA-ITC) to Conventional Itraconazole (C-ITC) for Treatment of Endemic Mycosis (EM)

  Oral Abstract